scispace - formally typeset
A

Ariadna Juarez-Garcia

Researcher at University of Birmingham

Publications -  19
Citations -  1232

Ariadna Juarez-Garcia is an academic researcher from University of Birmingham. The author has contributed to research in topics: Cost effectiveness & Internal medicine. The author has an hindex of 10, co-authored 16 publications receiving 1172 citations.

Papers
More filters
Journal ArticleDOI

Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation.

TL;DR: Flexible dosing of MMT and BMT appears to be similarly effective whether delivered in a primary care or outpatient clinic setting, and in a direct comparison, MMT was found to be slightly more effective and less costly than BMT.
Journal ArticleDOI

Methods of prediction and prevention of pre-eclampsia: Systematic reviews of accuracy and effectiveness literature with economic modelling

TL;DR: The economic model provided little support that any form of Doppler test has sufficiently high sensitivity and specificity to be cost-effective for the early identification of pre-eclampsia, and none of the tests appeared sufficiently accurate to be clinically useful.
Journal ArticleDOI

Oral naltrexone as a treatment for relapse prevention in formerly opioid-dependent drug users: a systematic review and economic evaluation.

TL;DR: The results suggest that naltrexone as maintenance therapy may be better than placebo in terms of retention in treatment, but this was not statistically significant and may be of limited clinical significance.
Journal ArticleDOI

The costs of epilepsy misdiagnosis in England and Wales.

TL;DR: There is a need for health care commissioners to ensure that misdiagnosis is kept to a minimum by ensuring that individuals with a recent onset suspected seizure are seen as soon as possible by a specialist medical practitioner with training and expertise in epilepsy.
Journal ArticleDOI

Cost-effectiveness of a disease management programme for secondary prevention of coronary heart disease and heart failure in primary care

TL;DR: The use of a nurse-led disease management programme is associated with increased costs in other coronary heart disease-related services as well as for the costs of the clinics, and they are also associated with improvements in health.